Overexpression of CD164 in oral cavity squamous cell carcinoma predicts a favourable prognosis.

ABSTRACT: The aim of the present study was to investigate the association between cluster of differentiation (CD) 164 expression with clinicopathological parameters and prognosis among patients with oral cavity squamous cell carcinoma (OSCC). The present study retrospectively reviewed 70 patients with OSCC who underwent curative primary surgery. A number of patients subsequently received postoperative chemoradiotherapy although the specimens were not exposed to radiation or chemotherapy prior to anti-CD164 antibody immunohistochemical staining. CD164 overexpression was arbitrarily defined as exhibiting an H-score of ≥120. Univariate and multivariate analyses were performed for sex, age, American Joint Committee on Cancer stage, tumour location, histological grade, surgical margin and H-score. The 5-

SUBMITTER: Chen JH 

PROVIDER: S-EPMC5661421 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature